4D Molecular Therapeutics
FDMT
$25.34
Share price
-1.17%
Change (1 day)
39.38%
Change (1 year)
Categories
4D Molecular Therapeutics (FDMT) - P/B ratio
P/B ratio as of May 2024 : 4.31
According to 4D Molecular Therapeutics's latest financial reports the company has a price-to-book ratio of 4.31.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
4D Molecular Therapeutics - P/B ratio (from 2020 to 2023)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2023-12-31 | 2.81 | -9.52% |
| 2022-12-31 | 3.11 | 40.74% |
| 2021-12-31 | 2.21 | -48.41% |
| 2020-12-31 | 4.28 | |
| 2019-12-31 | N/A | |
| 2018-12-31 | N/A |
P/B ratio for similar companies or competitors
| Company | P/B ratio | differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | 2.71 | -36.98% | 🇺🇸 USA |